China SXT Pharmaceuticals, Inc. (SXTC) stock
SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
$3.00+0.27 (+9.89%)
Close on Nov 13, 2026Market cap $2.87MP/E –Yield –
China SXT Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
China SXT Pharmaceuticals's cash was $28.18M at Mar 31, 2026. For fiscal 2026 it was $28.18M, up 55.7% from the year before. Over ten years it grew 118.3% a year on average. The highest annual figure on record is $28.18M in fiscal 2026.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $28.18M | +55.7% |
| FY2025 | Mar 31, 2025 | $18.10M | +49.9% |
| FY2024 | Mar 31, 2024 | $12.08M | -30.5% |
| FY2023 | Mar 31, 2023 | $17.37M | +11.6% |
| FY2022 | Mar 31, 2022 | $15.57M | +16.5% |
| FY2021 | Mar 31, 2021 | $13.36M | +83.3% |
| FY2020 | Mar 31, 2020 | $7.29M | -21.6% |
| FY2019 | Mar 31, 2019 | $9.29M | +1312.6% |
| FY2018 | Mar 31, 2018 | $657.77K | +903.2% |
| FY2017 | Mar 31, 2017 | $65.57K | +473.2% |
| FY2016 | Mar 31, 2016 | $11.44K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $28.18M | +133.3% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $21.17M | +84.6% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $18.10M | +4.2% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $18.51M | +521.0% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $12.08M | -22.4% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $11.47M | +36504.9% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $17.37M | +30.0% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $2.98M | -71.2% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $15.57M | +113.7% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $31.32K | -99.6% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $13.36M | +43.8% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $10.35M | +2599.0% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $7.29M | +1007.8% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $8.32M | +12595.2% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $9.29M | +81130.3% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $383.61K | – |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $657.77K | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $65.57K | – |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | $11.44K | – |
See a number that looks wrong?